List of bibliographic references
Number of relevant bibliographic references: 9.
| Ident. | Authors (with country if any) | Title |
|---|
| 000151 (2017) |
Bernard Leroy [France] ; Mandy L. Ballinger [Australie] ; Fanny Baran-Marszak [France] ; Gareth L. Bond [Royaume-Uni] ; Antony Braithwaite [Nouvelle-Zélande] ; Nicole Concin [Autriche] ; Lawrence A. Donehower [États-Unis] ; Wafik S. El-Deiry [États-Unis] ; Pierre Fenaux [France] ; Gianluca Gaidano [Italie] ; Anita Langer D [Norvège] ; Eva Hellstrom-Lindberg [Suède] ; Richard Iggo [France] ; Jacqueline Lehmann-Che [France] ; Phuong L. Mai [États-Unis] ; David Malkin [Canada] ; Ute M. Moll [États-Unis] ; Jeffrey N. Myers [États-Unis] ; Kim E. Nichols [États-Unis] ; Sarka Pospisilova [République tchèque] ; Patricia Ashton-Prolla [Brésil] ; Davide Rossi [Italie] ; Sharon A. Savage [États-Unis] ; Louise C. Strong [États-Unis] ; Patricia N. Tonin [Canada] ; Robert Zeillinger [Autriche] ; Thorsten Zenz [Allemagne] ; Joseph F. Fraumeni [États-Unis] ; Peter E M. Taschner [Pays-Bas] ; Pierre Hainaut [France] ; Thierry Soussi [France] | Recommended Guidelines for Validation, Quality Control, and Reporting of TP53 Variants in Clinical Practice. |
| 000426 (2017) |
Hartmut Döhner [Allemagne] ; Elihu Estey [États-Unis] ; David Grimwade [Royaume-Uni] ; Sergio Amadori [Italie] ; Frederick R. Appelbaum [États-Unis] ; Thomas Büchner [Allemagne] ; Hervé Dombret [France] ; Benjamin L. Ebert [États-Unis] ; Pierre Fenaux [France] ; Richard A. Larson [États-Unis] ; Ross L. Levine [États-Unis] ; Francesco Lo-Coco [Italie] ; Tomoki Naoe [Japon] ; Dietger Niederwieser [Allemagne] ; Gert J. Ossenkoppele [Pays-Bas] ; Miguel Sanz [Espagne] ; Jorge Sierra [Espagne] ; Martin S. Tallman [États-Unis] ; Hwei-Fang Tien [Taïwan] ; Andrew H. Wei [Australie] ; Bob Löwenberg [Pays-Bas] ; Clara D. Bloomfield [États-Unis] | Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel |
| 000508 (2017) |
Andre C. Schuh [Canada] ; Hartmut Döhner [Allemagne] ; Lisa Pleyer [Autriche] ; John F. Seymour [Australie] ; Pierre Fenaux [France] ; Hervé Dombret [France] | Azacitidine in adult patients with acute myeloid leukemia. |
| 000F60 (2014) |
Petter S. Woll [Royaume-Uni] ; Una Kj Llquist [Suède] ; Onima Chowdhury [Royaume-Uni] ; Helen Doolittle [Royaume-Uni] ; David C. Wedge [Royaume-Uni] ; Supat Thongjuea [Royaume-Uni] ; Rikard Erlandsson [Suède] ; Mtakai Ngara [Suède] ; Kristina Anderson [Norvège] ; Qiaolin Deng [Suède] ; Adam J. Mead [Royaume-Uni] ; Laura Stenson [Royaume-Uni] ; Alice Giustacchini [Royaume-Uni] ; Sara Duarte [Royaume-Uni] ; Eleni Giannoulatou [Royaume-Uni] ; Stephen Taylor [Royaume-Uni] ; Mohsen Karimi [Suède] ; Christian Scharenberg [Suède] ; Teresa Mortera-Blanco [Suède] ; Iain C. Macaulay [Royaume-Uni] ; Sally-Ann Clark [Royaume-Uni] ; Ingunn Dybedal [Norvège] ; Dag Josefsen [Norvège] ; Pierre Fenaux [France] ; Peter Hokland [Danemark] ; Mette S. Holm [Danemark] ; Mario Cazzola [Italie] ; Luca Malcovati [Italie] ; Sudhir Tauro [Royaume-Uni] ; David Bowen [Royaume-Uni] ; Jacqueline Boultwood [Royaume-Uni] ; Andrea Pellagatti [Royaume-Uni] ; John E. Pimanda [Australie] ; Ashwin Unnikrishnan [Australie] ; Paresh Vyas [Royaume-Uni] ; Gudrun Göhring [Allemagne] ; Brigitte Schlegelberger [Allemagne] ; Magnus Tobiasson [Suède] ; Gunnar Kvalheim [Norvège] ; Stefan N. Constantinescu [Belgique] ; Claus Nerlov [Royaume-Uni] ; Lars Nilsson [Suède] ; Peter J. Campbell [Royaume-Uni] ; Rickard Sandberg [Suède] ; Elli Papaemmanuil [Royaume-Uni] ; Eva Hellström-Lindberg [Suède] ; Sten Linnarsson [Suède] ; Sten Eirik W. Jacobsen [Suède] | Myelodysplastic syndromes are propagated by rare and distinct human cancer stem cells in vivo. |
| 001184 (2014) |
Aristoteles Giagounidis [Allemagne] ; Ghulam J. Mufti [Royaume-Uni] ; Pierre Fenaux [France] ; Mikkael A. Sekeres [États-Unis] ; Jeffrey Szer [Australie] ; Uwe Platzbecker [Allemagne] ; Andrea Kuendgen [Allemagne] ; Gianluca Gaidano [Italie] ; Wieslaw Wiktor-Jedrzejczak [Pologne] ; KUOLUNG HU [États-Unis] ; Paul Woodard [États-Unis] ; Allen S. Yang [États-Unis] ; Hagop M. Kantarjian [États-Unis] | Results of a Randomized, Double-Blind Study of Romiplostim Versus Placebo in Patients With Low/Intermediate-1-Risk Myelodysplastic Syndrome and Thrombocytopenia |
| 001818 (2012) |
Norbert Gattermann [Allemagne] ; Carlo Finelli [Italie] ; Matteo Della Porta [Italie] ; Pierre Fenaux [France] ; Michael Stadler [Allemagne] ; Agnes Guerci-Bresler [France] ; Mathias Schmid [Suisse] ; Kerry Taylor [Australie] ; Dominique Vassilieff [France] ; Dany Habr [États-Unis] ; Andrea Marcellari [États-Unis] ; Bernard Roubert [Suisse] ; Christian Rose [France] | Hematologic responses to deferasirox therapy in transfusion-dependent patients with myelodysplastic syndromes |
| 001B96 (2011) |
Lewis R. Silverman [États-Unis] ; Pierre Fenaux [France] ; Ghulam J. Mufti [Royaume-Uni] ; Valeria Santini [Italie] ; Eva Hellström-Lindberg [Suède] ; Norbert Gattermann [Allemagne] ; Guillermo Sanz [Espagne] ; Alan F. List [États-Unis] ; Steven D. Gore [États-Unis] ; John F. Seymour [Australie] | Continued Azacitidine Therapy Beyond Time of First Response Improves Quality of Response in Patients With Higher-Risk Myelodysplastic Syndromes |
| 001E04 (2010) |
Pierre Fenaux [France] ; Norbert Gattermann [Allemagne] ; John F. Seymour [Australie] ; Eva Hellström-Lindberg [Suède] ; Ghulam J. Mufti [Royaume-Uni] ; Ulrich Duehrsen [Allemagne] ; Steven D. Gore [États-Unis] ; Fernando Ramos [Espagne] ; Odile Beyne-Rauzy [France] ; Alan List [États-Unis] ; David Mckenzie [États-Unis] ; Jay Backstrom [États-Unis] ; Charles L. Beach [États-Unis] | Prolonged survival with improved tolerability in higher-risk myelodysplastic syndromes: azacitidine compared with low dose ara-C |
| 001E76 (2010) |
Pierre Fenaux [France, Royaume-Uni, Suède, Italie, Allemagne, Espagne, Australie, États-Unis] ; Ghulam J. Mufti ; Eva Hellstrom-Lindberg ; Valeria Santini ; Norbert Gattermann ; Ulrich Germing ; Guillermo Sanz ; Alan F. List ; Steven Gore ; John F. Seymour ; Hervé Dombret ; Jay Backstrom ; Linda Zimmerman ; David Mckenzie ; C. L. Beach ; Lewis R. Silverman | Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia |
List of associated KwdEn.i
Nombre de
documents | Descripteur |
|---|
| 4 | Myelodysplastic syndrome |
| 3 | Antineoplastic agent |
| 3 | Azacitidine |
| 3 | Cancerology |
| 3 | Comparative study |
| 3 | Human |
| 3 | Humans |
| 2 | Hematology |
| 2 | Prolonged |
| 2 | Risk factor |
| 2 | Survival |
| 2 | Treatment |
| 1 | Acute myelogenous leukemia |
| 1 | Adult |
| 1 | Animals |
| 1 | Antigens, CD (biosynthesis) |
| 1 | Antigens, CD (immunology) |
| 1 | Antineoplastic Agents (therapeutic use) |
| 1 | Blast |
| 1 | Bone marrow |
| 1 | Care |
| 1 | Chelating agent |
| 1 | Chemotherapy |
| 1 | Chromosome Deletion |
| 1 | Chromosomes, Human, Pair 5 |
| 1 | Consensus |
| 1 | Cytarabine |
| 1 | Deferasirox |
| 1 | Disease Management |
| 1 | Double blind study |
| 1 | Drug Administration Schedule |
| 1 | Elderly |
| 1 | Flow Cytometry |
| 1 | Gene Expression Profiling |
| 1 | Genetic Predisposition to Disease |
| 1 | Genetic Testing |
| 1 | Genetic Variation (genetics) |
| 1 | Hematopoietic Stem Cell Transplantation |
| 1 | Heterografts |
| 1 | Immunophenotyping |
| 1 | International Cooperation |
| 1 | Iron |
| 1 | Iron overload |
| 1 | Leukemia, Myeloid, Acute (classification) |
| 1 | Leukemia, Myeloid, Acute (diagnosis) |
| 1 | Leukemia, Myeloid, Acute (genetics) |
| 1 | Leukemia, Myeloid, Acute (therapy) |
| 1 | Low dose |
| 1 | Low risk |
| 1 | Mice |
| 1 | Mice, Inbred NOD |
| 1 | Mutation |
| 1 | Myelodysplastic Syndromes (genetics) |
| 1 | Myelodysplastic Syndromes (immunology) |
| 1 | Myelodysplastic Syndromes (pathology) |
| 1 | Neoplasm, Residual |
| 1 | Neoplasms (diagnosis) |
| 1 | Neoplasms (genetics) |
| 1 | Neoplasms (therapy) |
| 1 | Neoplastic Stem Cells (immunology) |
| 1 | Neoplastic Stem Cells (pathology) |
| 1 | Neoplastic Stem Cells (physiology) |
| 1 | Numeration |
| 1 | Pharmacotherapy |
| 1 | Placebo |
| 1 | Platelet |
| 1 | Practice Guidelines as Topic |
| 1 | Practice Guidelines as Topic (standards) |
| 1 | Prognosis |
| 1 | Quality |
| 1 | Quality Control |
| 1 | Randomization |
| 1 | Randomized controlled trial |
| 1 | Response time |
| 1 | Risk Factors |
| 1 | Romiplostim |
| 1 | Therapeutic protocol |
| 1 | Thrombocytopenia |
| 1 | Transfusion |
| 1 | Transplantation, Autologous |
| 1 | Treatment Outcome |
| 1 | Tumor Suppressor Protein p53 (genetics) |
| 1 | Validation Studies as Topic |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Allemagne/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i -k "Pierre Fenaux"
HfdIndexSelect -h $EXPLOR_AREA/Data/Allemagne/Analysis/Author.i \
-Sk "Pierre Fenaux" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Allemagne/Analysis/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Allemagne
|étape= Analysis
|type= indexItem
|index= Author.i
|clé= Pierre Fenaux
}}
| This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024 |  |
